Logo image of EXK

ENDEAVOUR SILVER CORP (EXK) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:EXK - CA29258Y1034 - Common Stock

8.865 USD
-0.54 (-5.69%)
Last: 12/2/2025, 12:17:05 PM
Fundamental Rating

3

EXK gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 154 industry peers in the Metals & Mining industry. EXK may be in some trouble as it scores bad on both profitability and health. EXK has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

EXK had negative earnings in the past year.
EXK had a positive operating cash flow in the past year.
EXK had positive earnings in 4 of the past 5 years.
In the past 5 years EXK always reported a positive cash flow from operatings.
EXK Yearly Net Income VS EBIT VS OCF VS FCFEXK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

EXK has a worse Return On Assets (-9.27%) than 70.78% of its industry peers.
EXK has a Return On Equity of -18.53%. This is in the lower half of the industry: EXK underperforms 68.83% of its industry peers.
EXK has a Return On Invested Capital (0.08%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for EXK is significantly below the industry average of 13.20%.
Industry RankSector Rank
ROA -9.27%
ROE -18.53%
ROIC 0.08%
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
EXK Yearly ROA, ROE, ROICEXK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

EXK has a Operating Margin of 0.23%. This is comparable to the rest of the industry: EXK outperforms 48.05% of its industry peers.
EXK's Operating Margin has declined in the last couple of years.
The Gross Margin of EXK (13.03%) is comparable to the rest of the industry.
EXK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.23%
PM (TTM) N/A
GM 13.03%
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
EXK Yearly Profit, Operating, Gross MarginsEXK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXK is destroying value.
The number of shares outstanding for EXK has been increased compared to 1 year ago.
Compared to 5 years ago, EXK has more shares outstanding
The debt/assets ratio for EXK is higher compared to a year ago.
EXK Yearly Shares OutstandingEXK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
EXK Yearly Total Debt VS Total AssetsEXK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 2.89 indicates that EXK is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of EXK (2.89) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.23 indicates that EXK is not too dependend on debt financing.
EXK's Debt to Equity ratio of 0.23 is in line compared to the rest of the industry. EXK outperforms 45.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 2.89
ROIC/WACC0.01
WACC8.86%
EXK Yearly LT Debt VS Equity VS FCFEXK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

EXK has a Current Ratio of 0.79. This is a bad value and indicates that EXK is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.79, EXK is doing worse than 89.61% of the companies in the same industry.
EXK has a Quick Ratio of 0.79. This is a bad value and indicates that EXK is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.57, EXK is doing worse than 87.66% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.57
EXK Yearly Current Assets VS Current LiabilitesEXK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

6

3. Growth

3.1 Past

The earnings per share for EXK have decreased strongly by -66.67% in the last year.
EXK shows a strong growth in Revenue. In the last year, the Revenue has grown by 49.22%.
Measured over the past years, EXK shows a quite strong growth in Revenue. The Revenue has been growing by 12.33% on average per year.
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
Revenue 1Y (TTM)49.22%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%167.26%

3.2 Future

Based on estimates for the next years, EXK will show a very strong growth in Earnings Per Share. The EPS will grow by 53.69% on average per year.
The Revenue is expected to grow by 39.07% on average over the next years. This is a very strong growth
EPS Next Y150.5%
EPS Next 2Y219.08%
EPS Next 3Y135.04%
EPS Next 5Y53.69%
Revenue Next Year96.05%
Revenue Next 2Y87.63%
Revenue Next 3Y58.97%
Revenue Next 5Y39.07%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXK Yearly Revenue VS EstimatesEXK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
EXK Yearly EPS VS EstimatesEXK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.2 -0.2 0.4 0.6 0.8

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXK. In the last year negative earnings were reported.
EXK is valuated correctly with a Price/Forward Earnings ratio of 13.55.
Based on the Price/Forward Earnings ratio, EXK is valued a bit cheaper than the industry average as 68.83% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of EXK to the average of the S&P500 Index (36.21), we can say EXK is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 13.55
EXK Price Earnings VS Forward Price EarningsEXK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as EXK.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 52.56
EXK Per share dataEXK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as EXK's earnings are expected to grow with 135.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y219.08%
EPS Next 3Y135.04%

0

5. Dividend

5.1 Amount

EXK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENDEAVOUR SILVER CORP

NYSE:EXK (12/2/2025, 12:17:05 PM)

8.865

-0.54 (-5.69%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)03-09 2026-03-09/amc
Inst Owners50.49%
Inst Owner Change19%
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap2.61B
Revenue(TTM)337.14M
Net Income(TTM)-94.29M
Analysts78.33
Price Target10.21 (15.17%)
Short Float %6.81%
Short Ratio1.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-354.6%
Min EPS beat(2)-595.05%
Max EPS beat(2)-114.14%
EPS beat(4)1
Avg EPS beat(4)-1434.73%
Min EPS beat(4)-5248.51%
Max EPS beat(4)218.79%
EPS beat(8)2
Avg EPS beat(8)-1023.35%
EPS beat(12)2
Avg EPS beat(12)-714.54%
EPS beat(16)3
Avg EPS beat(16)-577.87%
Revenue beat(2)2
Avg Revenue beat(2)8.49%
Min Revenue beat(2)0.04%
Max Revenue beat(2)16.94%
Revenue beat(4)3
Avg Revenue beat(4)0.1%
Min Revenue beat(4)-16.69%
Max Revenue beat(4)16.94%
Revenue beat(8)7
Avg Revenue beat(8)2.97%
Revenue beat(12)9
Avg Revenue beat(12)1.92%
Revenue beat(16)10
Avg Revenue beat(16)-0.39%
PT rev (1m)30.11%
PT rev (3m)47.79%
EPS NQ rev (1m)-25.81%
EPS NQ rev (3m)53.33%
EPS NY rev (1m)14.29%
EPS NY rev (3m)23.08%
Revenue NQ rev (1m)2.09%
Revenue NQ rev (3m)2.09%
Revenue NY rev (1m)4.71%
Revenue NY rev (3m)7.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.55
P/S 7.74
P/FCF N/A
P/OCF 55.51
P/B 5.13
P/tB 5.13
EV/EBITDA 52.56
EPS(TTM)-0.15
EYN/A
EPS(NY)0.65
Fwd EY7.38%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)0.16
OCFY1.8%
SpS1.15
BVpS1.73
TBVpS1.73
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -9.27%
ROE -18.53%
ROCE 0.1%
ROIC 0.08%
ROICexc 0.08%
ROICexgc 0.08%
OM 0.23%
PM (TTM) N/A
GM 13.03%
FCFM N/A
ROA(3y)-0.51%
ROA(5y)0.76%
ROE(3y)-0.98%
ROE(5y)0.74%
ROIC(3y)2.76%
ROIC(5y)N/A
ROICexc(3y)3.56%
ROICexc(5y)N/A
ROICexgc(3y)3.56%
ROICexgc(5y)N/A
ROCE(3y)3.5%
ROCE(5y)N/A
ROICexgc growth 3Y-31.89%
ROICexgc growth 5YN/A
ROICexc growth 3Y-31.88%
ROICexc growth 5YN/A
OM growth 3Y-2.72%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5YN/A
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA 2.06
Cap/Depr 321.73%
Cap/Sales 52.32%
Interest Coverage 0.06
Cash Conversion 84.51%
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.57
Altman-Z 2.89
F-Score3
WACC8.86%
ROIC/WACC0.01
Cap/Depr(3y)485.81%
Cap/Depr(5y)353.29%
Cap/Sales(3y)66.44%
Cap/Sales(5y)50.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-66.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.71%
EPS Next Y150.5%
EPS Next 2Y219.08%
EPS Next 3Y135.04%
EPS Next 5Y53.69%
Revenue 1Y (TTM)49.22%
Revenue growth 3Y9.6%
Revenue growth 5Y12.33%
Sales Q2Q%167.26%
Revenue Next Year96.05%
Revenue Next 2Y87.63%
Revenue Next 3Y58.97%
Revenue Next 5Y39.07%
EBIT growth 1Y-91.44%
EBIT growth 3Y6.61%
EBIT growth 5YN/A
EBIT Next Year219.22%
EBIT Next 3Y109.71%
EBIT Next 5Y52.95%
FCF growth 1Y-134.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.01%
OCF growth 3Y-6.61%
OCF growth 5YN/A

ENDEAVOUR SILVER CORP / EXK FAQ

What is the ChartMill fundamental rating of ENDEAVOUR SILVER CORP (EXK) stock?

ChartMill assigns a fundamental rating of 3 / 10 to EXK.


What is the valuation status for EXK stock?

ChartMill assigns a valuation rating of 4 / 10 to ENDEAVOUR SILVER CORP (EXK). This can be considered as Fairly Valued.


How profitable is ENDEAVOUR SILVER CORP (EXK) stock?

ENDEAVOUR SILVER CORP (EXK) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for EXK stock?

The Earnings per Share (EPS) of ENDEAVOUR SILVER CORP (EXK) is expected to grow by 150.5% in the next year.